Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junran Sun

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Cell Reports. Medicine|June 12, 2026
Subretinal rAAV2-based VEGF-Trap gene therapy for neovascular age-related macular degeneration: Preclinical assessment and phase 1 trial resultsTong Li, Jingyang Feng, Xiaolu Yang, et al.
Theranostics|October 14, 2020
ROS production and mitochondrial dysfunction driven by PU.1-regulated NOX4-p22<sup>phox</sup> activation in Aβ-induced retinal pigment epithelial cell injuryJunran Sun, Jieqiong Chen, Tong Li, et al.
American Journal of Ophthalmology|December 25, 2025
Geographic and Phenotypic Variability in RHO-Associated Retinopathy: Evidence from a Chinese Cohort and Global LiteratureChenyue Hang, Tianyuan Zhao, Zhixuan Chen, et al.
Retina (Philadelphia, Pa.)|February 2, 2023
OUTER RETINAL TUBULATION IN BIETTI CRYSTALLINE DYSTROPHY ASSOCIATED WITH THE RETINAL PIGMENT EPITHELIUM ATROPHYYusong Wang, Jieqiong Chen, Junran Sun, et al.
Investigative Ophthalmology & Visual Science|July 7, 2026
Enhanced Endocytosis and Mitochondrial Stress Underlie Severe Retinitis Pigmentosa With RHO P347L MutantChenyue Hang, Xinchao Shi, Tianyuan Zhao, et al.
Ophthalmology Science|October 6, 2025
Efficacy and Safety of Efdamrofusp Alfa with Personalized Dosing Intervals in Neovascular Age-Related Macular Degeneration: A Phase II TrialTong Li, Shiqi Yang, Qinghuai Liu, et al.
Ophthalmology. Retina|August 30, 2024
Efficacy and Safety of Efdamrofusp Alfa versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration: A Randomized, Double-Masked, Active-Controlled, Noninferiority, Phase II TrialJunran Sun, Yanping Song, Yuanyuan Gong, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Cell Reports. Medicine|June 12, 2026
Subretinal rAAV2-based VEGF-Trap gene therapy for neovascular age-related macular degeneration: Preclinical assessment and phase 1 trial resultsTong Li, Jingyang Feng, Xiaolu Yang, et al.
Theranostics|October 14, 2020
ROS production and mitochondrial dysfunction driven by PU.1-regulated NOX4-p22<sup>phox</sup> activation in Aβ-induced retinal pigment epithelial cell injuryJunran Sun, Jieqiong Chen, Tong Li, et al.
American Journal of Ophthalmology|December 25, 2025
Geographic and Phenotypic Variability in RHO-Associated Retinopathy: Evidence from a Chinese Cohort and Global LiteratureChenyue Hang, Tianyuan Zhao, Zhixuan Chen, et al.
Retina (Philadelphia, Pa.)|February 2, 2023
OUTER RETINAL TUBULATION IN BIETTI CRYSTALLINE DYSTROPHY ASSOCIATED WITH THE RETINAL PIGMENT EPITHELIUM ATROPHYYusong Wang, Jieqiong Chen, Junran Sun, et al.
Investigative Ophthalmology & Visual Science|July 7, 2026
Enhanced Endocytosis and Mitochondrial Stress Underlie Severe Retinitis Pigmentosa With RHO P347L MutantChenyue Hang, Xinchao Shi, Tianyuan Zhao, et al.
Ophthalmology Science|October 6, 2025
Efficacy and Safety of Efdamrofusp Alfa with Personalized Dosing Intervals in Neovascular Age-Related Macular Degeneration: A Phase II TrialTong Li, Shiqi Yang, Qinghuai Liu, et al.
Ophthalmology. Retina|August 30, 2024
Efficacy and Safety of Efdamrofusp Alfa versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration: A Randomized, Double-Masked, Active-Controlled, Noninferiority, Phase II TrialJunran Sun, Yanping Song, Yuanyuan Gong, et al.
Pageof 5